Contraception
Volume 79, Issue 6 , Pages 418-423 , June 2009

Intrauterine devices for adolescents: a systematic review

  • Elizabeth I. Deans
    • ,
  • David A. Grimes

      Affiliations

    • Corresponding Author InformationCorresponding author. Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709, USA. Tel.: +1 919 544 7040; fax: +1 919 544 7261.

Received 20 November 2008 ,Accepted 23 December 2008.

References 

  1. Guttmacher Institute . Facts on American teens' sexual and reproductive health. http://www.guttmacher.org/pubs/fb_ATSRH.htmlAccessed August 27, 2008
  2. Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med. 1994;331:1201–1206
  3. Zibners A, Cromer BA, Hayes J. Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol. 1999;12:90–94
  4. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982–2002. Adv Data. 2004;1–36
  5. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77:10–21
  6. ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents. Obstet Gynecol. 2007;110:1493–1495
  7. World Health Organization . Medical eligibility criteria for contraceptive use, 3rd ed. http://www.who.int/reproductive-health/publications/MEC_3/index.htmAccessed February 11, 2005
  8. Blythe MJ, Diaz A. Contraception and adolescents. Pediatrics. 2007;120:1135–1148
  9. Stedman's Medical Dictionary. 27th ed. Philadelphia: Lippincott Williams & Wilkins; 2000;
  10. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002;31:115–123
  11. Cates W, Ory HW, Rochat RW, Tyler CW. The intrauterine device and deaths from spontaneous abortion. N Engl J Med. 1976;295:1155–1159
  12. Jorgensen V. One-year contraceptive follow-up of adolescent patients. Am J Obstet Gynecol. 1973;115:484–486
  13. Goldman JA, Dekel A, Reichman J. Immediate postabortion intrauterine contraception in nulliparous adolescents. Isr J Med Sci. 1979;15:522–525
  14. Goldman JA, Reichman J. Contraception in the teenager. A comparison of four methods of contraception in adolescent girls. Isr J Med Sci. 1980;16:510–513
  15. Diaz J, Pinto Neto AM, Bahamondes L, Diaz M, Arce XE, Castro S. Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women?. Contraception. 1993;48:23–28
  16. Larsson B, Hagstrom B, Viberg L, Anker C, Hamberger L, Lindhe BA. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard. Contraception. 1979;20:291–295
  17. Larsson B, Rodau S, Patek E. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation. Contracept Deliv Syst. 1981;2:237–242
  18. Lane ME, Sobrero AJ. Experience with intrauterine contraception by adolescent women. Mt Sinai J Med. 1975;42:337–344
  19. Weiner E, Berg AA, Johansson I. Copper intrauterine contraceptive devices in adolescent nulliparae. Br J Obstet Gynaecol. 1978;85:204–206
  20. Kulig JW, Rauh JL, Burket RL, Cabot HM, Brookman RR. Experience with the copper 7 intrauterine device in an adolescent population. J Pediatr. 1980;96:746–750
  21. Larsson B, Hagstrom B, Viberg L, Hamberger L. Long-term clinical experience with the Cu-7-IUD. Evaluation of a prospective study. Contraception. 1981;23:387–397
  22. Weiner E, Berg AA, Helmius G, Johansson I. Contraception for teenage girls. Combination pill or IUD?. Acta Obstet Gynecol Scand Suppl. 1979;88:65–69
  23. Booth M, Beral V, Guillebaud J. Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. Br Med J. 1980;281:114
  24. Wildemeersch D, Van Kets H, Vrijens M, et al. Intrauterine contraception in adolescent women. The GyneFix intrauterine implant. Ann N Y Acad Sci. 1997;816:440–450
  25. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception. 2004;69:407–412
  26. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356:1013–1019
  27. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006;CD006034
  28. Stanback J, Grimes D. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis. Contraception. 1998;58:357–360
  29. Sivin I, Stern J. Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970–75. Stud Fam Plann. 1979;10:263–281
  30. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272–1277
  31. Singh K, Fong YF, Prasad RN, Dong F. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?. Br J Obstet Gynaecol. 1999;106:266–269
  32. Saav I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22:2647–2652
  33. Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol. 1991;77:261–264
  34. Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a meta-analysis of the randomized controlled trials. Contraception. 1999;60:57–63
  35. Whitaker AK, Gilliam M. Contraceptive care for adolescents. Clin Obstet Gynecol. 2008;51:268–280
  36. Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study. Am J Obstet Gynecol. 1989;160:391–396
  37. Skjeldestad F, Bratt H. Fertility after complicated and non-complicated use of IUDs. A controlled prospective study. Adv Contracept. 1988;4:179–184
  38. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception. 1992;46:575–584
  39. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001;345:561–567
  40. Whitaker AK, Johnson LM, Harwood B, Chiappetta L, Creinin MD, Gold MA. Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device. Contraception. 2008;78:211–217
  41. Stanwood NL, Bradley KA. Young pregnant women's knowledge of modern intrauterine devices. Obstet Gynecol. 2006;108:1417–1422
  42. Gold MA, Johnson LM. Intrauterine devices and adolescents. Curr Opin Obstet Gynecol. 2008;20:464–469
  43. Rickert VI, Grimes DA. Start now or start something else?. J Adolesc Health. 2008;43:419–420

PII: S0010-7824(08)00578-7

doi: 10.1016/j.contraception.2008.12.009

Contraception
Volume 79, Issue 6 , Pages 418-423 , June 2009

Article Tools